Results 61 to 70 of about 379 (102)

[Comprehensive management of tophaceous wound]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
He G, Lu S, Lu X, Liu Y.
europepmc   +1 more source

伊贝沙坦对糖尿病大鼠肾氧化应激65380;NF-κB活性和 ICAM-1 mRNA表达的影响

Zhongshan Daxue xuebao. Yixue kexue ban, 2008
【目的】 探讨伊贝沙坦对糖尿病大鼠肾脏氧化应激65380;NF-κB活性和ICAM-1 mRNA表达水平的影响65377; 【方法】 将33 只SD大鼠随机分为3 组:正常对照组(C)65380;糖尿病组(D)和伊贝沙坦组(I)65377;糖尿病大鼠模型用链脲佐菌素诱导65377;大鼠饲养12周后,观察24h尿微量白蛋白排泄率(UAER),取出肾脏作肾组织病理检查,测定肾组织中丙二醛(MDA)含量与超氧化物歧化酶(SOD)65380;过氧化氢酶(CAT)65380;谷胱苷肽过氧化物酶(GSH-PX ...
doaj  

[Efficacy and safety of empagliflozin in the treatment of glycogen storage disease-associated inflammatory bowel disease]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Liang DX, Wu HT, Yang J, Yang M.
europepmc   +1 more source

[Quantitative determination of tetrodotoxin in poisoned biological samples by two-dimensional liquid chromatography-tandem mass spectrometry]. [PDF]

Se Pu
Fang L, Qiu FM, Wang YC.
europepmc   +1 more source

Bioinformatics analysis of a <i>CLCN5</i> geneframeshift mutation in a patient with Dent disease. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhang Y, Li N, Fan L, Liu J.
europepmc   +1 more source

Treatment and management for children with urea cycle disorder in chronic stage. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023
Huang X.
europepmc   +1 more source

[Interpretation of the "Expert consensus on the diagnosis and treatment of neonatal hyperammonemia"]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Cai C, Zhao W, Hao H, Shi Y.
europepmc   +1 more source

[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban, 2023
Fang C, Sun L, Liu Y, Xiao L, Sun L.
europepmc   +1 more source

[Preoperative serum magnesium as a biomarker for predicting delirium following non-cardiac surgery in elderly patients: a retrospective cohort study]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yuan M, Ruan X, Li Y, Zhang T, Hao C, Li H, Lou J, Cao J, Liu Y, Mi W, Zhang X.   +10 more
europepmc   +1 more source

[Exposures to volatile organic compounds are positively correlated with risks of metabolic dysfunction-associated steatotic liver disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li K, Zeng W, Zhang Y, Zhu X, Guo B.
europepmc   +1 more source